MedPath

TRIESENCE

TRIESENCE

Approved
DIN Number

02368676

Drug Class

Human

Market Date

Aug 22, 2012

Company
HC

novartis pharmaceuticals canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02368676
AIG Number0106310006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01BA05 TRIAMCINOLONE
Product Specifications
Dosage FormSuspension
Route of AdministrationIntravitreal
AHFS Classification52:08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

TRIAMCINOLONE ACETONIDEActive
Strength: 40 MG / ML
Monograph: TRIAMCINOLONE ACETONIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.